{
    "2018-06-25": [
        [
            {
                "time": "2018-06-23",
                "original_text": "【医药-复星医药(600196)】江琦、张天翼：拟开展国内首个单抗联合用药临床试验，产品协同性有望逐渐体现-20180623",
                "features": {
                    "keywords": [
                        "复星医药",
                        "单抗联合用药",
                        "临床试验",
                        "产品协同性"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-23",
                "original_text": "复星医药: 出售HLX02部分海外权益, 生物药研发实力再获证明",
                "features": {
                    "keywords": [
                        "复星医药",
                        "HLX02",
                        "海外权益",
                        "生物药研发"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-23",
                "original_text": "[买入评级]复星医药(600196/02196.HK)重大事项点评：转让HLX02海外权益意义重大 公司单抗研发水平已接轨国际",
                "features": {
                    "keywords": [
                        "复星医药",
                        "HLX02",
                        "海外权益",
                        "单抗研发"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-23",
                "original_text": "【权益变动】复星医药(02196-HK)遭The Capital Group减持103.35万股 涉资4671.73万",
                "features": {
                    "keywords": [
                        "复星医药",
                        "减持",
                        "The Capital Group"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-06-23",
                "original_text": "医药短期回调哪些优质龙头值得重点关",
                "features": {
                    "keywords": [
                        "医药",
                        "短期回调",
                        "优质龙头"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-06-23",
                "original_text": "【策略】估值在底部区域，但看得清未来才会大行情",
                "features": {
                    "keywords": [
                        "估值",
                        "底部区域",
                        "未来",
                        "大行情"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}